Prokidney
PROK · NASDAQ
$1.44+$0.045 (+3.23%)TodayMarket closed ·
Prev close $1.40
EPS: actual vs estimate
Beat the estimate in 5 of the last 8 quarters, by 9.6% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.1435 | -$0.15 | −4.5% |
| Q1 FY26 | -$0.1408 | -$0.14 | +0.6% |
| Q4 FY25 | -$0.124 | -$0.14 | −12.9% |
| Q3 FY25 | -$0.1346 | -$0.12 | +10.8% |
| Q2 FY25 | -$0.1469 | -$0.13 | +11.5% |
| Q1 FY25 | -$0.1607 | -$0.13 | +19.1% |
| Q4 FY24 | -$0.1515 | -$0.17 | −12.2% |
| Q3 FY24 | -$0.1489 | -$0.14 | +6.0% |
Earnings calls
- 44th Annual J.P. Morgan Healthcare Conference
- Morgan Stanley 23rd Annual Global Healthcare Conference
- Citi's Biopharma Back to School Conference
- 43rd Annual J.P. Morgan Healthcare Conference 2025
- UBS Virtual Organ Restoration and Cell Therapy Day
- Morgan Stanley 22nd Annual Global Healthcare Conference
- Special Call - ProKidney Corp.
- Special Call - ProKidney Corp.
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.